首页> 美国政府科技报告 >Vaccination with Dendritic Cell Myeloma Fusions in Conjunction With Stem Cell Transplantation and PD1 Blockade.

【24h】

Vaccination with Dendritic Cell Myeloma Fusions in Conjunction With Stem Cell Transplantation and PD1 Blockade.

机译：与干细胞移植和pD1阻断相结合的树突状细胞骨髓瘤融合疫苗接种。

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Most patients with multiple myeloma achieve a complete or near complete response following autologous transplantation. However, patients experience disease relapse from a persistent reservoir of chemotherapy resistant disease. There has been strong intere

著录项

作者
Avigan, D.;
展开▼
作者单位

展开▼
年度 2013
页码 1-12
总页数 12
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Myeloma; Stem cells; Vaccines; Antibodies; Capacity(Quantity); Cells(Biology); Clinical medicine; Dendritic structure; Diseases; Immunity; Immunization; Immunology; Immunosuppression; Immunotherapy; In vivo analysis; Models; Neoplasms; Patients; Reservoirs; Resistance; Respo;

机译：骨髓瘤;干细胞;疫苗;抗体;能力（数量）;细胞（生物学）;临床医学;树突结构;疾病;免疫;免疫;免疫学;免疫抑制;免疫疗法;体内分析;模型;肿瘤;患者;水库;抗性; Respo;
入库时间 2022-08-29 10:49:53

相似文献

外文文献
中文文献
专利

1. Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients [J] . RosenblattJ., AviviI., VasirB., Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第13期

机译：自体干细胞移植后接种树突状细胞/肿瘤融合蛋白疫苗可诱导多发性骨髓瘤患者的免疫学和临床反应
2. Partial T Cell-Depleted Allogeneic Stem Cell Transplantation following Reduced-Intensity Conditioning Creates a Platform for Immunotherapy with Donor Lymphocyte Infusion and Recipient Dendritic Cell Vaccination in Multiple Myeloma [J] . Henriette Levenga, Nicolaas Schaap, Frans Maas, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2010,第3期

机译：强度降低后的部分T细胞贫乏同种异体干细胞移植为多发性骨髓瘤的供体淋巴细胞输注和接受树突状细胞疫苗接种创造了免疫治疗的平台。
3. Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation. [J] . Bendandi M, Rodriguez Calvillo M, Inoges S, Leukemia and lymphoma . 2006,第1期

机译：降低强度条件的同种异体干细胞移植后复发的多发性骨髓瘤患者的联合接种与独特型脉冲同种异体树突状细胞和可溶性蛋白独特型。
4. Transplantable Matrix Permits T Cell and Dendritic-Fusion Cell Interaction [C] . Kristie M. Charoen, Tania Konry, Smadar Cohen, Society for biomaterials annual meeting and exposition . 2013

机译：可移植基质允许T细胞和树突融合细胞相互作用
5. Dendritic cell vaccination for relapse after allogeneic transplantation . [D] . Osman, Keren. 2011

机译：同种异体移植后树突状细胞疫苗的复发。
6. Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients [O] . Jacalyn Rosenblatt, Irit Avivi, Baldev Vasir, -1

机译：自体干细胞移植后接种树突状细胞/肿瘤融合蛋白疫苗可诱导多发性骨髓瘤患者的免疫学和临床反应
7. 63: Vaccination with dendritic cell myeloma fusions alone or in conjunction with stem cell transplantation for patients with multiple myeloma [O] . Avigan D., Rosenblatt J., Vasir B., 2007

机译：63：对多发性骨髓瘤患者单独或与干细胞移植联合接种树突状细胞骨髓瘤疫苗

Vaccination with Dendritic Cell Myeloma Fusions in Conjunction With Stem Cell Transplantation and PD1 Blockade.

摘要

著录项

相似文献

相关主题

期刊订阅